Textiles Press Releases
SEE OTHER BRANDS

Your best source on the textile industry news from the world

Textiles Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Textiles Press Releases.

Press releases published on August 11, 2025

Longeveron Announces Closing Of Up To $17.5 Million Public Offering

Longeveron Announces Closing Of Up To $17.5 Million Public Offering

MIAMI, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related …

Tonix Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Highlights

Tonix Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Highlights

FDA PDUFA goal date of August 15, 2025, for TNX‑102 SL for fibromyalgia: if approved by FDA, TNX‑102 SL would be the first new drug for fibromyalgia in more than 16 years  In June 2025, the Company was added to the Russell 3000® and Russell 2000® Indexes …

AMD to Host Financial Analyst Day on November 11, 2025

AMD to Host Financial Analyst Day on November 11, 2025

SANTA CLARA, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) announced it will host its 2025 Financial Analyst Day on Tuesday, Nov. 11, 2025, in New York City. The event will feature presentations from AMD’s executive leadership team, …

3D Systems Reports Second Quarter 2025 Financial Results

3D Systems Reports Second Quarter 2025 Financial Results

ROCK HILL, S.C., Aug. 11, 2025 (GLOBE NEWSWIRE) -- 3D Systems Corporation (NYSE:DDD) announced today its financial results for the second quarter ended June 30, 2025. Revenue of $95 million led by double-digit growth in Medical Technology and Aerospace …

Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update

Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update

Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in China Granted orphan drug designation from the European Medicines Agency (EMA) for amezalpat for the treatment of patients …

Life360 Reports Record Q2 2025 Results

Life360 Reports Record Q2 2025 Results

Monthly Active Users Reached Approximately 88.0 million; Up 25% Year-Over-Year Record Q2 Global Net Additions of 136 thousand Paying Circles, Reaching 2.5 million Total Total Quarterly Revenue Increased 36% Year-Over-Year to $115.4 million Annualized …

Heidmar Maritime Holdings Corp. Reports Second Quarter 2025 Results

Heidmar Maritime Holdings Corp. Reports Second Quarter 2025 Results

ATHENS, Greece and NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Heidmar Maritime Holdings Corp. (the "Company" or "Heidmar") (NASDAQ: HMR) today reported its results for the quarter and six month period ended June 30, 2025. Second Quarter 2025 Highlights …

FutureFuel Releases Second Quarter 2025 Results

FutureFuel Releases Second Quarter 2025 Results

CLAYTON, Mo., Aug. 11, 2025 (GLOBE NEWSWIRE) -- FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a manufacturer of custom and performance chemicals and biofuels, today announced financial results for the second quarter ended June 30, 2025. Second quarter 2025  …

Maravai LifeSciences Reports Second Quarter 2025 Financial Results

Maravai LifeSciences Reports Second Quarter 2025 Financial Results

Announced organizational restructuring and operating cost reduction initiatives targeting more than $50 million in annualized cost savings Quarterly base business revenue, which excludes revenue from high-volume CleanCap® for commercialized vaccine …

PubMatic Announces Second Quarter 2025 Financial Results

PubMatic Announces Second Quarter 2025 Financial Results

Delivered revenue and adjusted EBITDA ahead of guidance; Revenue from omnichannel video, including CTV, grew 34% year-over-year and was 41% of total revenue; CTV revenue grew over 50% year-over-year; Supply Path Optimization represented 55%+ of total …

Crinetics Pharmaceuticals Announces August 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals Announces August 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on August 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of …

Globus Maritime Announces Annual Meeting of Shareholders

Globus Maritime Announces Annual Meeting of Shareholders

GLYFADA, Greece, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Globus Maritime Limited (“Globus” or the “Company”) (NASDAQ: GLBS), a dry bulk shipping company, announced today that the annual meeting of shareholders will be held at the offices of Globus Shipmanagement …

VirTra Reports Second Quarter and Six Months 2025 Financial Results

VirTra Reports Second Quarter and Six Months 2025 Financial Results

Second Quarter Revenue Increases 15% Year-Over-Year; Six-Month Revenue Up 5% Delivers Continued Positive Net Income and Strong Gross Margins as Federal Funding Trends Improve CHANDLER, Ariz., Aug. 11, 2025 (GLOBE NEWSWIRE) -- VirTra, Inc. (Nasdaq: VTSI) (“ …

IMDX Reports Q2 2025 Results and Momentum Toward GraftAssureDx Launch

IMDX Reports Q2 2025 Results and Momentum Toward GraftAssureDx Launch

Reiterating timelines for FDA submission in 2025 Transplant clinical trial has attracted leading transplant hospitals Booked first revenue from first-generation GraftAssureIQ research-use-only kits; began shipping second generation kits in June NASHVILLE, …

Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date July 31, 2025

Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date July 31, 2025

NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of July 31, 2025, short interest in 3,285 Nasdaq Global MarketSM securities totaled 13,683,072,188 shares compared with 13,792,841,090 shares in 3,260 Global Market issues …

Metagenomi Appoints Laurence Reid, PhD to its Board of Directors

Metagenomi Appoints Laurence Reid, PhD to its Board of Directors

EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX) (the “Company”), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing toolbox, today …

Main Street Financial Services, Corp. Announces Opening of Full-Service Branch in St. Clairsville, Ohio

Main Street Financial Services, Corp. Announces Opening of Full-Service Branch in St. Clairsville, Ohio

WOOSTER, Ohio, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Main Street Financial Services, Corp. (OTCQX: MSWV), the holding company for Main Street Bank, is pleased to announce the opening of a full-service branch in St. Clairsville, Ohio. The new location, situated …

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Second Quarter 2025 Financial Results on August 14, 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Second Quarter 2025 Financial Results on August 14, 2025

WILMINGTON, Del., Aug. 11, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that it will release its second quarter 2025 financial results …

Capricor Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Capricor Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Type A meeting with U.S. FDA scheduled to discuss Deramiocel BLA and path toward potential approval Capricor seeks to resubmit its BLA based on its existing dataset, with HOPE-3 data (expected in Q4 2025) potentially serving as supportive and confirmatory …

Life360 Names COO Lauren Antonoff as Chief Executive Officer

Life360 Names COO Lauren Antonoff as Chief Executive Officer

Co-Founder Chris Hulls will serve as Executive Chairman of the Board Planned leadership succession signals continued investment in product innovation and growth SAN FRANCISCO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Life360 (Nasdaq: LIF), the category-defining …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions